XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Why Is Stacks (STX) Price Down Today? Key Drivers
Stacks (STX) is trading at $0.320609 as of November 3, 2026, down 5.18% over the past 24 hours as sellers pushed the token to its lowest level in recent session...
Tether Freezes $4.5M USDT Tied to Mercado Bitcoin Breach
Tether has frozen $4.5 million in USDT linked to a breach at Mercado Bitcoin, the Brazilian crypto exchange.
New Jersey Drops Coinbase Lawsuit, Allowing Crypto Staking to Resume
New Jersey has dropped its lawsuit against Coinbase, clearing the way for the exchange to resume crypto staking services for eligible customers in the state.
Why Is Pump.fun (PUMP) Price Down Today? Drivers to Watch
Pump.fun (PUMP) is trading at $0.00408859 on November 2, 2026, down 3.82% over the past 24 hours. The move extends a period of soft price action for the token,...
Robinhood Q3 Revenue Reaches $1.42B as Crypto Income Drops 55%
Robinhood posted $1.42 billion in total Q3 2025 revenue, while crypto-specific income dropped 55% in the same period, according to the company’s official earnin...
THORChain Glitch Blocks Binance Hack Route as FBI Presses Nodes
The reported glitch affected THORChain’s cross-chain swap infrastructure, creating an outage on a route law enforcement had flagged as active in moving hack-lin...
